Epsilon M&A Deal Report - AdnaGen
Transaction Multiples for the Valuation of Private Companies
Alere Holdings Bermuda Ltd / AdnaGen
No EMAT :
22029
Announced Date :
28/10/2010
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Alere Holdings Bermuda Ltd
Target :
AdnaGen
Country :
Germany
Sector of activity :
- Health, Pharmaceuticals & Biotechnology > Biotechnology
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
Business Description :
Founded in 1999, AdnaGen AG, a biotechnology research and development company, engages in the development of tumor diagnostics for the detection and molecular analysis of tumor cells . > Proprietary...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
ns | ns | |||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biotechnology » = 43
- Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 55
| Date | Acquirer | Target | Country | Multiples | See details |
| 11/11/2010 | Meda | Norgine Portfolio of Three OTC Products | Netherlands | *** | 21980 |
| 03/11/2010 | Wilex | Heidelberg Pharma | Germany | ** | 21959 |
Source: Epsilon Research / EMAT
